May 21, 2019 / 12:00PM GMT
Sebastian Walker - UBS Investment Bank, Research Division - Associate Analyst
Good morning, everybody. Thank you for making it in. And so my name is Sebastian Walker. I'm the European medical device analyst at UBS. And this morning, first up, we have Dr. Achim von Leoprechting, who is the CEO of Tecan, recently taking over.
In terms of the format, so we'll start off with a 25-minute presentation or so and then we'll make our way to Alvin/Carnegie for a breakout session. Instructions as well, I believe, were on the screen on how to ask Q&A. Maybe we could have those up one more time for people, just in case they missed them. Thank you.
Achim von Leoprechting - Tecan Group Ltd. - Head of the Partnering Business Division, CEO & Member of Management Board
So good morning, and thank you very much for joining the presentation on Tecan. It's my pleasure to be here with you, and thanks also to UBS for the invitation. I'm Achim von Leoprechting. I'm the CEO of the company. I took over on April 1 after having been with the company for 5.5 years leading
Tecan Group AG at UBS Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot